Mouse models to study polycystic ovary syndrome: A possible link between metabolism and ovarian function?
Tóm tắt
Từ khóa
Tài liệu tham khảo
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), Hum Reprod, 19, 41, 10.1093/humrep/deh098
2001, Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486
Balen, 1995, Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients, Hum Reprod, 10, 2107, 10.1093/oxfordjournals.humrep.a136243
Sir-Petermann, 2009, Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome, J Clin Endocrinol Metab, 94, 1923, 10.1210/jc.2008-2836
Cook, 2002, Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women, Fertil Steril, 77, 141, 10.1016/S0015-0282(01)02944-2
Fallat, 1997, Mullerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis, Fertil Steril, 67, 962, 10.1016/S0015-0282(97)81417-3
Wild, 2002, Long-term health consequences of PCOS, Hum Reprod Update, 8, 231, 10.1093/humupd/8.3.231
Bronstein, 2011, Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought, J Pediatr Adolesc Gynecol, 24, 15, 10.1016/j.jpag.2010.06.003
Franks, 2002, Adult polycystic ovary syndrome begins in childhood, Best Pract Res Clin Endocrinol Metab, 16, 263, 10.1053/beem.2002.0203
Blank, 2006, The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome, Hum Reprod Update, 12, 351, 10.1093/humupd/dml017
Franks, 1999, Insulin action in the normal and polycystic ovary, Endocrinol Metab Clin North Am, 28, 361, 10.1016/S0889-8529(05)70074-8
Franks, 2000, Follicular dynamics in the polycystic ovary syndrome, Mol Cell Endocrinol, 163, 49, 10.1016/S0303-7207(99)00239-7
Laven, 2004, Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age, J Clin Endocrinol Metab, 89, 318, 10.1210/jc.2003-030932
Corbould, 2007, Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women, J Endocrinol, 192, 585, 10.1677/joe.1.07070
Abbott, 2002, Developmental origin of polycystic ovary syndrome - a hypothesis, J Endocrinol, 174, 1, 10.1677/joe.0.1740001
Eisner, 2000, Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys, J Clin Endocrinol Metab, 85, 1206
Robinson, 1999, In utero exposure of female lambs to testosterone reduces the sensitivity of the gonadotropin-releasing hormone neuronal network to inhibition by progesterone, Endocrinology, 140, 5797, 10.1210/endo.140.12.7205
Blouin, 2008, Androgens and body fat distribution, J Steroid Biochem Mol Biol, 108, 272, 10.1016/j.jsbmb.2007.09.001
Dunaif, 1989, Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome, Diabetes, 38, 1165, 10.2337/diab.38.9.1165
Escobar-Morreale, 2007, Abdominal adiposity and the polycystic ovary syndrome, Trends Endocrinol Metab, 18, 266, 10.1016/j.tem.2007.07.003
Poretsky, 1988, The effects of experimental hyperinsulinemia on steroid secretion, ovarian [125I]insulin binding, and ovarian [125I]insulin-like growth-factor I binding in the rat, Endocrinology, 122, 581, 10.1210/endo-122-2-581
Abbott, 2009, Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys, Am J Primatol, 71, 776, 10.1002/ajp.20679
Hogg, 2012, Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome, Endocrinology, 153, 450, 10.1210/en.2011-1607
King, 2007, Hypertension caused by prenatal testosterone excess in female sheep, Am J Phys Endocrinol Metab, 292, E1837, 10.1152/ajpendo.00668.2006
Padmanabhan, 2010, Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females, Endocrinology, 151, 595, 10.1210/en.2009-1015
Shi, 2012, Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk, Fertil Steril, 98, 185, 10.1016/j.fertnstert.2012.04.006
Walters, 2012, Rodent models for human polycystic ovary syndrome, Biol Reprod, 86, 10.1095/biolreprod.111.097808
Skinner, 2005, Regulation of primordial follicle assembly and development, Hum Reprod Update, 11, 461, 10.1093/humupd/dmi020
Bristol-Gould, 2006, Postnatal regulation of germ cells by activin: the establishment of the initial follicle pool, Dev Biol, 298, 132, 10.1016/j.ydbio.2006.06.025
Sugiyama, 2010, ERbeta: recent understanding of estrogen signaling, Trends Endocrinol Metab, 21, 545, 10.1016/j.tem.2010.05.001
Moore, 2013, Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome, Endocrinology, 154, 796, 10.1210/en.2012-1954
Roland, 2011, Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthood, Endocrinology, 152, 618, 10.1210/en.2010-0823
Roland, 2010, Prenatal androgen exposure programs metabolic dysfunction in female mice, J Endocrinol, 207, 213, 10.1677/JOE-10-0217
Sullivan, 2004, Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder, Proc Natl Acad Sci U S A, 101, 7129, 10.1073/pnas.0308058101
Eagleson, 2000, Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone, J Clin Endocrinol Metab, 85, 4047
Lei, 2010, The interactions between the stimulatory effect of follicle-stimulating hormone and the inhibitory effect of estrogen on mouse primordial folliculogenesis, Biol Reprod, 82, 13, 10.1095/biolreprod.109.077404
van Houten, 2012, Reproductive and metabolic phenotype of a mouse model of PCOS, Endocrinology, 153, 2861, 10.1210/en.2011-1754
Manneras, 2007, A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome, Endocrinology, 148, 3781, 10.1210/en.2007-0168
Pirwany, 2001, Circulating leptin concentrations and ovarian function in polycystic ovary syndrome, Eur J Endocrinol, 145, 289, 10.1530/eje.0.1450289
Xu, 2005, Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes, J Biol Chem, 280, 18073, 10.1074/jbc.M414231200
Yu, 1997, Role of leptin in hypothalamic–pituitary function, Proc Natl Acad Sci U S A, 94, 1023, 10.1073/pnas.94.3.1023
Karlsson, 1997, Expression of functional leptin receptors in the human ovary, J Clin Endocrinol Metab, 82, 4144
Zachow, 1999, Leptin impairs the synergistic stimulation by transforming growth factor-beta of follicle-stimulating hormone-dependent aromatase activity and messenger ribonucleic acid expression in rat ovarian granulosa cells, Biol Reprod, 61, 1104, 10.1095/biolreprod61.4.1104
Lu, 2008, Adiponectin activates adenosine monophosphate-activated protein kinase and decreases luteinizing hormone secretion in LbetaT2 gonadotropes, Mol Endocrinol, 22, 760, 10.1210/me.2007-0330
Wen, 2008, Globular adiponectin inhibits GnRH secretion from GT1-7 hypothalamic GnRH neurons by induction of hyperpolarization of membrane potential, Biochem Biophys Res Commun, 371, 756, 10.1016/j.bbrc.2008.04.146
Lagaly, 2008, Role of adiponectin in regulating ovarian theca and granulosa cell function, Mol Cell Endocrinol, 284, 38, 10.1016/j.mce.2008.01.007
Weyer, 2001, Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia, J Clin Endocrinol Metab, 86, 1930, 10.1210/jcem.86.5.7463
Beloosesky, 2004, Induction of polycystic ovary by testosterone in immature female rats: modulation of apoptosis and attenuation of glucose/insulin ratio, Int J Mol Med, 14, 207
Demissie, 2008, Transient prenatal androgen exposure produces metabolic syndrome in adult female rats, Am J Phys Endocrinol Metab, 295, E262, 10.1152/ajpendo.90208.2008
Hillier, 1979, Effects of exogenous testosterone on ovarian weight, follicular morphology and intraovarian progesterone concentration in estrogen-primed hypophysectomized immature female rats, Biol Reprod, 20, 261, 10.1095/biolreprod20.2.261
Tyndall, 2012, Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats, Reproduction, 143, 21, 10.1530/REP-11-0239
Edwards, 1971, Neonatal administration of androstenedione, testosterone or testosterone propionate: effects on ovulation, sexual receptivity and aggressive behavior in female mice, Physiol Behav, 6, 223, 10.1016/0031-9384(71)90030-8
Kamijo, 1994, In vitro fertilization of androgen sterilized mice, Life Sci, 55, 527, 10.1016/0024-3205(94)00745-4
Liu, 2000, Effects of recombinant human FSH (rhFSH), urinary purified FSH (uFSH), and hMG on small preantral follicles and tertiary follicles from normal adult and androgen-sterilized female mice, Fertil Steril, 73, 372, 10.1016/S0015-0282(99)00494-X
Loughlin, 1986, Adrenal abnormalities in polycystic ovary syndrome, J Clin Endocrinol Metab, 62, 142, 10.1210/jcem-62-1-142
Sander, 2005, The influence of dehydroepiandrosterone on early pregnancy in mice, Neuroimmunomodulation, 12, 285, 10.1159/000087106
Elia, 2006, The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice, Mol Hum Reprod, 12, 475, 10.1093/molehr/gal057
Sander, 2006, Role of the N,N′-dimethylbiguanide metformin in the treatment of female prepuberal BALB/c mice hyperandrogenized with dehydroepiandrosterone, Reproduction, 131, 591, 10.1530/rep.1.00941
Solano, 2011, Systemic inflammation, cellular influx and up-regulation of ovarian VCAM-1 expression in a mouse model of polycystic ovary syndrome (PCOS), J Reprod Immunol, 92, 33, 10.1016/j.jri.2011.09.003
Yaba, 2012, The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS), J Ovarian Res, 5, 38, 10.1186/1757-2215-5-38
Wu, 2007, Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome, Hum Reprod, 22, 527, 10.1093/humrep/del371
Schmidt, 2013, Differential expression of inflammation-related genes in the ovarian stroma and granulosa cells of PCOS women, Mol Hum Reprod
Fulghesu, 2011, IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance, Mediators Inflamm, 10.1155/2011/389317
El-Mesallamy, 2013, Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome, Eur J Obstet Gynecol Reprod Biol, 168, 178, 10.1016/j.ejogrb.2013.01.015
Suganami, 2012, Adipose tissue inflammation and ectopic lipid accumulation, Endocr J, 59, 849, 10.1507/endocrj.EJ12-0271
Schenk, 2008, Insulin sensitivity: modulation by nutrients and inflammation, Eur J Clin Invest, 118, 2992, 10.1172/JCI34260
Wu, 2010, High-fat diet causes lipotoxicity responses in cumulus-oocyte complexes and decreased fertilization rates, Endocrinology, 151, 5438, 10.1210/en.2010-0551
Chapman, 2009, The estrogen-injected female mouse: new insight into the etiology of PCOS, Reprod Biol Endocrinol, 7, 47, 10.1186/1477-7827-7-47
Tanriverdi, 2003, The hypothalamic–pituitary–gonadal axis: immune function and autoimmunity, J Endocrinol, 176, 293, 10.1677/joe.0.1760293
Hefler-Frischmuth, 2010, Serologic markers of autoimmunity in women with polycystic ovary syndrome, Fertil Steril, 93, 2291, 10.1016/j.fertnstert.2009.01.056
Palacio, 2006, The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients, Clin Exp Immunol, 144, 217, 10.1111/j.1365-2249.2006.03061.x
Fenichel, 1999, Polycystic ovary syndrome in autoimmune disease, Lancet, 353, 2210, 10.1016/S0140-6736(99)00256-1
Novosad, 2003, Ovarian antibodies as detected by indirect immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation, BMC Womens Health, 3, 2, 10.1186/1472-6874-3-2
Rojansky, 1997, Polycystic ovary syndrome. An autoimmune disease?, J Reprod Med, 42, 325
Petrikova, 2012, Ovarian failure and polycystic ovary syndrome, Autoimmun Rev, 11, A471, 10.1016/j.autrev.2011.11.010
Janssen, 2004, High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome, Eur J Endocrinol, 150, 363, 10.1530/eje.0.1500363
Garelli, 2013, High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome, Eur J Obstet Gynecol Reprod Biol, 169, 248, 10.1016/j.ejogrb.2013.03.003
Paavonen, 1994, Hormonal regulation of immune responses, Ann Med, 26, 255, 10.3109/07853899409147900
Kumar, 1999, Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis, Mol Endocrinol, 13, 851, 10.1210/mend.13.6.0297
Matzuk, 2003, Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice, Biol Reprod, 69, 338, 10.1095/biolreprod.102.013953
Meehan, 2005, Gonadal defects and hormonal alterations in transgenic mice expressing a single chain human chorionic gonadotropin–lutropin receptor complex, J Mol Endocrinol, 34, 489, 10.1677/jme.1.01669
Risma, 1995, Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors, Proc Natl Acad Sci U S A, 92, 1322, 10.1073/pnas.92.5.1322
Rulli, 2002, Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin, Endocrinology, 143, 4084, 10.1210/en.2002-220490
Britt, 2000, An age-related ovarian phenotype in mice with targeted disruption of the Cyp 19 (aromatase) gene, Endocrinology, 141, 2614, 10.1210/endo.141.7.7578
Couse, 1999, Prevention of the polycystic ovarian phenotype and characterization of ovulatory capacity in the estrogen receptor-alpha knockout mouse, Endocrinology, 140, 5855, 10.1210/endo.140.12.7222
Huhtaniemi, 2005, Multiple sites of tumorigenesis in transgenic mice overproducing hCG, Mol Cell Endocrinol, 234, 117, 10.1016/j.mce.2004.10.013
Kero, 2003, Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion, Am J Phys Endocrinol Metab, 285, E812, 10.1152/ajpendo.00367.2002
Pasquali, 2011, PCOS Forum: research in polycystic ovary syndrome today and tomorrow, Clin Endocrinol, 74, 424, 10.1111/j.1365-2265.2010.03956.x
Devin, 2007, Transgenic overexpression of plasminogen activator inhibitor-1 promotes the development of polycystic ovarian changes in female mice, J Mol Endocrinol, 39, 9, 10.1677/JME-06-0057
Diebold, 2008, The ‘PAI-1 paradox’ in vascular remodeling, Thromb Haemost, 100, 984
Hernestal-Boman, 2012, Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study, Cardiovasc Diabetol, 11, 152, 10.1186/1475-2840-11-152
De Pergola, 1997, Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution, Int J Obes Relat Metab Disord, 21, 527, 10.1038/sj.ijo.0800435
Gonzalez, 2013, Elevated circulating levels of tissue factor in polycystic ovary syndrome, Clin Appl Thromb Hemost, 19, 66, 10.1177/1076029612436673
Koiou, 2012, Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome, Endocr J, 59, 21, 10.1507/endocrj.EJ11-0023
Sampson, 1996, Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome, Clin Endocrinol, 45, 623, 10.1046/j.1365-2265.1996.00863.x
Urbanek, 2007, Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype, J Clin Endocrinol Metab, 92, 4191, 10.1210/jc.2007-0761
Lansdown, 2012, The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?, Clin Endocrinol, 77, 791, 10.1111/cen.12003
Dissen, 2009, Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans, Endocrinology, 150, 2906, 10.1210/en.2008-1575
Lara, 2000, An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat, Endocrinology, 141, 1059, 10.1210/endo.141.3.7395
Hill, 2010, Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility, Cell Metab, 11, 286, 10.1016/j.cmet.2010.03.002
Marino, 2012, Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation, PLoS ONE, 7, e48643, 10.1371/journal.pone.0048643
Xu, 2011, Cross-talk between metabolism and reproduction: the role of POMC and SF1 neurons, Front Endocrinol, 2, 98
Varela, 2012, Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis, EMBO Rep, 13, 1079, 10.1038/embor.2012.174
Hughesdon, 1982, Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called “hyperthecosis”, Obstet Gynecol Survey, 37, 59, 10.1097/00006254-198202000-00001
Franks, 2008, Follicle dynamics and anovulation in polycystic ovary syndrome, Hum Reprod Update, 14, 367, 10.1093/humupd/dmn015
Champy, 2008, Genetic background determines metabolic phenotypes in the mouse, Mamm Genome, 19, 318, 10.1007/s00335-008-9107-z